The Advanced Therapies Congress is Europe’s largest commercial conference and exhibition dedicated to cell and gene therapy and other advanced therapy medicinal products (ATMPs), bringing together senior leaders, innovators, and decision-makers from pharmaceutical, biotech, clinical, regulatory, and payer communities to share insights and drive the field forward. This event features hundreds of expert speakers, extensive content across multiple tracks covering the full ATMP value chain—from clinical development and manufacturing to regulatory, market access, logistics, and emerging technologies—plus an exhibition of leading solution providers, opportunities for networking and collaboration, and showcases of cutting-edge research and startups.

Date: March 17-18, 2026
Location: ExCeL London, United Kingdom

JOIN US!

Complete the form to schedule a meeting with our experts!

SPEAKING ENGAGEMENTS

Speaker: Sima Hirani, Field Application Scientist, Catalent
Date/Time: Tuesday 17^th March 2026, 2:35-2:55 PM
Title: Accelerating Advanced Therapies: Practical Solutions to Achieve Manufacturing Success

ABOUT CATALENT

Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) championing the missions that help people live better and healthier lives. Every product that Catalent helps develop, manufacture and launch reflects its commitment to improve health outcomes around the world through its Patient First approach. Catalent provides unparalleled service to pharma, biotech and consumer health customers, delivering on their missions to transform lives. Catalent tailors end-to-end solutions to meet customers’ needs in all phases of development and manufacturing. With thousands of scientists and technicians and the latest technology platforms at more than 40 global sites, Catalent supplies billions of doses of life-enhancing and life-saving treatments for patients annually. For more information, visit www.catalent.com.

 

Championing the missions that matter™